Saturday, June 14, 2025
  • Who’sWho Africa AWARDS
  • About Time Africa Magazine
  • Contact Us
Time Africa Magazine
  • Home
  • Magazine
  • WHO’SWHO AWARDS
  • News
  • World News
    • US
    • UAE
    • Europe
    • UK
    • Israel-Hamas
    • Russia-Ukraine
  • Politics
  • Crime
  • Lifestyle
  • Sports
  • Column
  • Interviews
  • Special Report
No Result
View All Result
Time Africa Magazine
  • Home
  • Magazine
  • WHO’SWHO AWARDS
  • News
  • World News
    • US
    • UAE
    • Europe
    • UK
    • Israel-Hamas
    • Russia-Ukraine
  • Politics
  • Crime
  • Lifestyle
  • Sports
  • Column
  • Interviews
  • Special Report
No Result
View All Result
Time Africa Magazine
No Result
View All Result
  • Home
  • WHO’SWHO AWARDS
  • News
  • Magazine
  • World News

Home » Column » Cancer Vaccine Hailed as ‘Game-changer’

Cancer Vaccine Hailed as ‘Game-changer’

June 12, 2024
in Column, Featured
0
543
SHARES
4.5k
VIEWS
Share on FacebookShare on Twitter

By Jess Thomson, Science Reporter

Cancer patients in the U.K. are about to get personalized cancer vaccines as part of a new trial.

These “game-changer” vaccines are a form of immunotherapy, designed to prime the body’s immune system so that it can locate and fight tumor cells, reducing the chances of the cancer returning.

Unlike vaccines for diseases like the flu or COVID-19, which are taken to prevent someone from developing a disease, these cancer vaccines treat people who already have the condition.

Several National Health Service sites across England will be involved in the trial, which will initially focus on colorectal, pancreatic, skin, lung, bladder and kidney cancer patients. The vaccines in this trial will be manufactured by biotech company BioNTech SE.

ReadAlso

Appendix Cancer Has Quadrupled in Millennials

Ghanaian Nurse Naomi Ohene Oti wins 2025 Global Nursing Award for cancer care work

“It’s incredibly exciting that patients in England are beginning to access personalised cancer vaccines for bowel cancer,” Iain Foulkes, the executive director of research and innovation at Cancer Research UK, said in an NHS statement.

“This technology pioneers the use of mRNA-based vaccines to sensitise people’s immune system and in turn detect and target cancer at its earliest stages,” he said. “Clinical trials like this are vital in helping more people live longer, better lives, free from the fear of cancer. If successful, the vaccine will be a game-changer in preventing the onset or return of bowel cancer.”

ADVERTISEMENT

Vaccines for diseases like smallpox work by training the body’s immune system to recognize and fight off specific germs, like viruses or bacteria, without causing the disease. The vaccine contains a harmless part of the germ (like a protein, a dead or weakened form of the germ, or a piece of its genetic material), which the immune system recognizes as foreign and responds by producing antibodies.

The immune system then creates memory cells that “remember” the germ and can quickly produce these antibodies, which stay in the body for a long time. If the actual germ ever invades the body in the future, the immune system can quickly recognize and attack it using the memory cells and antibodies, preventing the person from getting sick or reducing the severity of the illness.

The cancer vaccines work by analyzing a patient’s cancer or tumor, and then creating a custom vaccine that contains markers that are on their cancer cells. In a similar way to infectious disease vaccines, the immune system then learns to recognize these markers—called antigens—and becomes primed to fight any cells that have them, namely, cancer cells.

“These vaccines teach the patient’s immune system to recognize and destroy cancer cells. The vaccine is tailored to the molecules expressed by the cancer cells of each patient (this is why it’s called “personalized”). This design should make the treatment more effective,” Francesco Crea, a professor of cancer pharmacology at the U.K.’s Open University, told Newsweek.

It is hoped this treatment will be used in tandem with surgery, chemotherapy and radiotherapy to prevent the return of cancers, and may have fewer side effects than the other treatments.

“We know that even after a successful operation, cancers can sometimes return because a few cancer cells are left in the body, but using a vaccine to target those remaining cells may be a way to stop this happening,” Peter Johnson, NHS national clinical director for cancer, said in the NHS statement.

The first NHS patient to receive the trial vaccine was Elliot Pfebve, a 55-year-old who had previously had surgery to remove his colorectal cancer tumor along with a portion of his bowel, as well as chemotherapy.

“Taking part in this trial tallies with my profession as a lecturer, and as a community-centred person. I want to impact other people’s lives positively and help them realise their potential,” Pfebve said in the statement.

“Through the potential of this trial, if it is successful, it may help thousands, if not millions of people, so they can have hope, and may not experience all I have gone through. I hope this will help other people,” he said.

The trial will only be completed in 2027, however, so it will be many years until this treatment is available for everyone. BioNTech SE will present preliminary data from the trial on June 1 at the American Society of Clinical Oncology’s annual conference in Chicago.

“The science behind the development of these cancers is solid, and the mRNA delivery platform has proven its efficacy during the COVID pandemic. So I am broadly optimistic,” Crea said. “However, cancer is a complex and difficult to understand disease. I expect that in some cancer types vaccines may work very well on their own, in others cancer types vaccines may need to be combined with other therapies.

“Sadly, for some cancers we may see that these vaccines are not effective. This is why we need to develop a multimodal approach to cancer treatment and to broaden our therapeutic armamentarium as much as we can.”

Source: Newsweek

Tags: CancerVaccines
ADVERTISEMENT
Previous Post

Japan, South Korea Have Serious Population Problem

Next Post

Pope Francis Uses Anti-Gay Slur—Again

You MayAlso Like

Featured

What caused Air India flight to crash? Here’s what investigators are looking for

June 12, 2025
Column

Throwing Away The Scientists Is Delivering A Growing Food Crisis

June 11, 2025
Featured

Trump travel ban targets nations mired in civil wars or armed conflicts

June 8, 2025
Elon Musk and Donald Trump's tumultuous relationship may be nearing its end. (ABC News: Brianna Morris-Grant; Reuters: Nathan Howard; Reuters: Kent Nishimura)
Column

Inside the battles that shattered Trump and Musk’s alliance

June 8, 2025
A nurse administers a malaria vaccine to an infant at the Lumumba Sub County Hospital in Kisumu, Kenya, on July 1, 2022 [Baz Ratner/Reuters]
Column

Malaria: The urgent need for a new prevention pact in Africa

June 7, 2025
Column

Nigeria’s Minister of Information: After Aid Cuts in Africa, Only Markets Can Deliver

June 6, 2025
Next Post

Pope Francis Uses Anti-Gay Slur—Again

Smoke billows as a result of rockets launched from Lebanon into northern Israel, next to the city of Kiryat Shmona by the border with Lebanon, on June 4, 2024, amid ongoing cross-border clashes between Israeli troops and Hezbollah fighters. Since the outbreak of war between the Palestinian militant group Hamas and Israel on October 7, the Lebanese-Israeli border area has witnessed near-daily exchanges of fire, mainly between the Israeli army and Hamas ally Hezbollah. (Photo by JACK GUEZ / AFP) (Photo by JACK GUEZ/AFP via Getty Images)

Hezbollah Fires Rockets at Northern Israel Amid Gaza Ceasefire Negotiations

Discussion about this post

Study reveals exact number of times women should have sex per week

Uchenna Okafor Honoured with African Icons and Heroes Award for Community Development

UK-bound Air India with plane crashes with 242 people on board

What caused Air India flight to crash? Here’s what investigators are looking for

How Nigeria’s Justice Minister Quietly ‘Cleansed’ Fidelity Bank MD from Billion-Naira Fraud Case

Club World Cup 2025: Full schedule, fixtures, dates and venues for Chelsea and Man City

  • British government apologizes to Peter Obi, as hired impostors, master manipulators on rampage abroad

    1236 shares
    Share 494 Tweet 309
  • Maids trafficked and sold to wealthy Saudis on black market

    1063 shares
    Share 425 Tweet 266
  • Flight Attendant Sees Late Husband On Plane

    965 shares
    Share 386 Tweet 241
  • ‘Céline Dion Dead 2023’: Singer killed By Internet Death Hoax

    900 shares
    Share 360 Tweet 225
  • Crisis echoes, fears grow in Amechi Awkunanaw in Enugu State

    734 shares
    Share 294 Tweet 184
  • Trending
  • Comments
  • Latest

British government apologizes to Peter Obi, as hired impostors, master manipulators on rampage abroad

April 13, 2023

Maids trafficked and sold to wealthy Saudis on black market

December 27, 2022
Flight Attendant Sees Late Husband On Plane

Flight Attendant Sees Late Husband On Plane

September 22, 2023
‘Céline Dion Dead 2023’: Singer killed By Internet Death Hoax

‘Céline Dion Dead 2023’: Singer killed By Internet Death Hoax

March 21, 2023
Chief Mrs Ebelechukwu, wife of Willie Obiano, former governor of Anambra state

NIGERIA: No, wife of Biafran warlord, Bianca Ojukwu lied – Ebele Obiano:

0

SOUTH AFRICA: TO LEAVE OR NOT TO LEAVE?

0
kelechi iheanacho

TOP SCORER: IHEANACHA

0
Goodluck Ebele Jonathan

WHAT CAN’TBE TAKEN AWAY FROM JONATHAN

0

Gov. Soludo: ‘President Tinubu Rescued The Economy From The Tipping Point, Returned Public Finance To Solvency’

June 13, 2025

Man United want £85m striker, Liverpool eye Osimhen, Arsenal fight Bayern for winger

June 13, 2025

Fury grows in Kenya after death of blogger in police custody

June 13, 2025

Israel strikes Iran’s nuclear sites

June 13, 2025

ABOUT US

Time Africa Magazine

TIME AFRICA MAGAZINE is an African Magazine with a culture of excellence; a magazine without peer. Nearly a third of its readers hold advanced degrees and include novelists, … READ MORE >>

SECTIONS

  • Aviation
  • Column
  • Crime
  • Europe
  • Featured
  • Gallery
  • Health
  • Interviews
  • Israel-Hamas
  • Lifestyle
  • Magazine
  • Middle-East
  • News
  • Politics
  • Press Release
  • Russia-Ukraine
  • Science
  • Special Report
  • Sports
  • TV/Radio
  • UAE
  • UK
  • US
  • World News

Useful Links

  • AllAfrica
  • Channel Africa
  • El Khabar
  • The Guardian
  • Cairo Live
  • Le Republicain
  • Magazine: 9771144975608
  • Subscribe to TIME AFRICA biweekly news magazine

    Enjoy handpicked stories from around African continent,
    delivered anywhere in the world

    Subscribe

    • About Time Africa Magazine
    • Privacy Policy
    • Contact Us
    • WHO’SWHO AWARDS

    © 2025 Time Africa Magazine - All Right Reserved. Time Africa is a trademark of Times Associates, registered in the U.S, & Nigeria. Use of this site constitutes acceptance of our Terms of Service.

    No Result
    View All Result
    • WHO’SWHO AWARDS
    • Politics
    • Column
    • Interviews
    • Gallery
    • Lifestyle
    • Special Report
    • Sports
    • TV/Radio
    • Aviation
    • Health
    • Science
    • World News

    © 2025 Time Africa Magazine - All Right Reserved. Time Africa is a trademark of Times Associates, registered in the U.S, & Nigeria. Use of this site constitutes acceptance of our Terms of Service.

    This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.